SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-22-000072
Filing Date
2022-09-21
Accepted
2022-09-21 17:23:35
Documents
15
Period of Report
2022-09-20
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alpn-20220920.htm   iXBRL 8-K 45521
2 EX-1.1 alpn-ex11xunderwritingagre.htm EX-1.1 223478
3 EX-5.1 alpn-ex51opinionfollowxon2.htm EX-5.1 15274
7 GRAPHIC image_1a.jpg GRAPHIC 74541
  Complete submission text file 0001626199-22-000072.txt   579536

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20220920.xsd EX-101.SCH 1951
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20220920_lab.xml EX-101.LAB 24849
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20220920_pre.xml EX-101.PRE 13082
9 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20220920_htm.xml XML 11265
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 221257416
SIC: 2834 Pharmaceutical Preparations